Covestor LTD Ocular Therapeutix, Inc Transaction History

Covestor LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$2.08 - $4.52 $62,148 - $135,053	-29,879 Reduced 79.88%	7,525 $34,000
Q3 2023 Nov 13, 2023	BUY	$3.14 - $5.04 $5,429 - $8,714	1,729 Added 4.85%	37,404 $117,000
Q2 2023 Aug 11, 2023	SELL	$4.6 - $7.64 $111,931 - $185,904	-24,333 Reduced 40.55%	35,675 $184,000
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $120,943 - $271,798	43,349 Added 260.21%	60,008 $316,000
Q4 2022 Feb 13, 2023	BUY	$2.61 - $4.41 $43,479 - $73,466	16,659 New	16,659 $46,000

Q1 2022 May 13, 2022	SELL	$4.83 - $7.35 $0 - $0	0 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$6.16 - $12.07 $0 - $0	0 New	0 $0

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.